MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE >  MONEYCONTROL MARKETS SHAREHOLDING PATTERN

PROMOTER AND PROMOTER GROUP

Godavari Drugs
BSE: 530317|ISIN: INE362C01012|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 22, 17:00
9.05
0
VOLUME 602
Godavari Drugs is not listed on NSE

Quarter Ending:September 2011

Shareholding belonging to the category : "Promoter and Promoter Group"

No.

Name of the Shareholder

Total Shares held

Shares pledged or otherwise encumbered

Number

As a % of
grand total
(A) + (B) + (C)

Number

% of Total shares held

As a % of
grand total
(A) + (B) + (C)

1

Sushma Kakani

852,400

11.32

100,000

11.73

1.33

2

Kamala Jaju

824,500

10.95

-

-

-

3

Mukund Kakani

323,100

4.29

-

-

-

4

Prakash Chandra Shrimal

335,883

4.46

80,000

23.82

1.06

5

Ghanshyam Jaju

341,600

4.54

-

-

-

6

Mohit Jaju

223,400

2.97

-

-

-

7

Mangala Shrimal

197,000

2.62

197,000

100

2.62

8

Kirti Kumar Jain

108,400

1.44

90,000

83.03

1.2

9

Anuradha Karanjgaokar

100,000

1.33

-

-

-

10

Vrunda Karanjgaokar

100,000

1.33

-

-

-

11

Ashwini Karanjgaokar

100,000

1.33

-

-

-

12

Karanjgaokar

80,000

1.06

-

-

-

13

Jayashree Jain

44,500

0.59

27,000

60.67

0.36

14

Neeraj Jain

17,900

0.24

-

-

-

15

Manish Jain

16,000

0.21

-

-

-

16

Mohit Jain

16,000

0.21

-

-

-

17

Kirti Kumar Jain

12,957

0.17

-

-

-

18

Ghanshyam Jaju HUF

2,200

0.03

-

-

-

Total

3,695,840

49.08

494,000

13.37

6.56

Quick Links for Godavari Drugs
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.